Health
Recurring glioblastomas with very few mutations are far more vulnerable to immunotherapies – News-Medical.Net
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling…
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Duke’s Preston Robert Tisch Brain Tumor Center provide potential answers. The team found that recurring glioblastoma…
-
General23 hours agoWondering about winter | The Spectator Australia
-
Noosa News22 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General21 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Noosa News20 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls